(Q54381660)

29 May 2018

title

Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer. (English)

1 reference

29 May 2018

author name string

I Teneng

1

1 reference

29 May 2018

C S Tellez

2

1 reference

29 May 2018

M A Picchi

3

1 reference

29 May 2018

D M Klinge

4

1 reference

29 May 2018

C M Yingling

5

1 reference

29 May 2018

A M Snider

6

1 reference

29 May 2018

Y Liu

7

1 reference

29 May 2018

S A Belinsky

8

1 reference

29 May 2018

language of work or name

English

0 references

publication date

27 January 2014

1 reference

29 May 2018

published in

Oncogene

1 reference

29 May 2018

volume

34

1 reference

29 May 2018

issue

5

1 reference

29 May 2018

page(s)

621-630

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1038/onc.2013.580

exact match

0 references

cites work

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

The changing epidemiology of lung cancer in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

DNA hypermethylation in tumorigenesis: epigenetics joins genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Cancer epigenetics comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Comprehensive genomic characterization of squamous cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Dnmt3a and Dnmt1 functionally cooperate during de novo methylation of DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

DNA methyltransferase Dnmt1 associates with histone deacetylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

EZH2 methyltransferase and H3K27 methylation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

The Polycomb group protein EZH2 directly controls DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

An essential role for DNA methyltransferase DNMT3B in cancer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Identification of methylated genes associated with aggressive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Mitotic and mitogenic Wnt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

cDNA cloning and sequence of MAL, a hydrophobic protein associated with human T-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Cloning and characterization of MVP17: a developmentally regulated myelin protein in oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

MAL promoter hypermethylation as a novel prognostic marker in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

GATA2 is epigenetically repressed in human and mouse lung tumors and is not requisite for survival of KRAS mutant lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.580

Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer

31 March 2020

1 reference

12 December 2020

Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity

1 reference

12 December 2020

Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.

1 reference

12 December 2020

Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.

1 reference

12 December 2020

Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression

1 reference

12 December 2020

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

1 reference

12 December 2020

Identifiers

DOI

10.1038/ONC.2013.580

1 reference

29 May 2018

1 reference

29 May 2018